Anaphylaxis News and Research

RSS
Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.
New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis

New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis

Milk ladder approach offers hope for children with cow's milk allergy

Milk ladder approach offers hope for children with cow's milk allergy

FDA approves omalizumab for food allergy reactions based on NIH research

FDA approves omalizumab for food allergy reactions based on NIH research

New insights on how diet regulates allergic responses

New insights on how diet regulates allergic responses

Nutrigenomics paves the way for customized diets in lactose intolerance care

Nutrigenomics paves the way for customized diets in lactose intolerance care

What is the association between prenatal opioid exposure and risk of immune-related conditions?

What is the association between prenatal opioid exposure and risk of immune-related conditions?

Breakthrough nano-shield blocks selective allergic reactions

Breakthrough nano-shield blocks selective allergic reactions

Two new practice parameters offer recommendations for treating anaphylaxis and atopic dermatitis

Two new practice parameters offer recommendations for treating anaphylaxis and atopic dermatitis

Advancements in food allergy research promise improved diagnosis and treatment options

Advancements in food allergy research promise improved diagnosis and treatment options

Targeted therapy reduces markers of disease burden, improves symptoms for patients with nonadvanced system mastocytosis

Targeted therapy reduces markers of disease burden, improves symptoms for patients with nonadvanced system mastocytosis

Food allergies may be linked to increased cardiovascular death risk, study finds

Food allergies may be linked to increased cardiovascular death risk, study finds

New method could enhance the ability to detect and predict anaphylaxis during oral food challenges

New method could enhance the ability to detect and predict anaphylaxis during oral food challenges

Balancing act: Navigating elimination diets in allergic kids without compromising nutrition

Balancing act: Navigating elimination diets in allergic kids without compromising nutrition

New survey uncovers lack of awareness about the proper use of adrenaline pens

New survey uncovers lack of awareness about the proper use of adrenaline pens

Self‐administration of investigational intranasal spray may be a new option to treat rapid heartbeat

Self‐administration of investigational intranasal spray may be a new option to treat rapid heartbeat

Could a genetic biomarker predict your risk for severe food allergies?

Could a genetic biomarker predict your risk for severe food allergies?

Using ChatGPT to address vaccine hesitancy: a promising tool for guiding users to scientific information?

Using ChatGPT to address vaccine hesitancy: a promising tool for guiding users to scientific information?

Novavax's protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data shows

Novavax's protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data shows

Early life food allergy associated with increased risk of asthma and reduced lung growth

Early life food allergy associated with increased risk of asthma and reduced lung growth

New precision medicine trial shows promise for treating rare brain tumors

New precision medicine trial shows promise for treating rare brain tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.